GW Pharma Investors Ink $7.75M Deal In Suit Over Jazz Sale
GW Pharmaceuticals investors urged a California federal judge on Monday to grant preliminary approval to a $7.75 million settlement that ends their claims the British company misled shareholders to push through...To view the full article, register now.
Already a subscriber? Click here to view full article